AlphaQuest LLC Increases Holdings in National Research Co. (NASDAQ:NRC)

AlphaQuest LLC grew its holdings in National Research Co. (NASDAQ:NRC) by 111.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 19,188 shares of the company’s stock after acquiring an additional 10,133 shares during the quarter. AlphaQuest LLC owned about 0.08% of National Research worth $338,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Geode Capital Management LLC raised its stake in National Research by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 420,733 shares of the company’s stock worth $9,619,000 after acquiring an additional 13,039 shares in the last quarter. State Street Corp grew its holdings in shares of National Research by 4.0% during the third quarter. State Street Corp now owns 363,438 shares of the company’s stock worth $8,351,000 after purchasing an additional 14,144 shares during the last quarter. QV Investors Inc. increased its position in shares of National Research by 4.5% during the fourth quarter. QV Investors Inc. now owns 354,360 shares of the company’s stock worth $6,251,000 after purchasing an additional 15,370 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of National Research by 88.5% in the 4th quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock valued at $3,832,000 after purchasing an additional 101,957 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of National Research in the 3rd quarter valued at about $3,158,000. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Trading Up 1.6 %

NASDAQ:NRC opened at $14.83 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 52-week low of $13.74 and a 52-week high of $40.69. The stock’s 50 day moving average price is $16.51 and its 200 day moving average price is $18.64. The company has a market capitalization of $348.15 million, a PE ratio of 14.12 and a beta of 0.47.

National Research (NASDAQ:NRC) last announced its earnings results on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.